Cancer Treatment News

Regeneron Pharma Stock Surges: Fresh Institutional Buying Insights

2 min

THMA Oncology Forum: Key Insights and Discussions Day 1

oncology · 6 min

XtalPi-Enabled PEP08 PRMT5 Inhibitor Begins Phase I Cancer Trial Enrollment

2 min

Arvinas Receives FDA Approval for VEPPANU (Vepdegestrant), First PROTAC Drug for ESR1-Mutated Breast Cancer

FDA · Oncology - Breast Cancer · 3 min

Sun Pharma Acquires Organon for $11.75 Billion in Major Pharmaceutical Merger

Multiple therapeutic areas (women's health, biosimilars, established brands) · 3 min

Phanes Therapeutics to Present Updated Spevatamig Phase 2 Results for Metastatic Pancreatic Cancer at ASCO 2026

2 min

AACR 2024: Daily Oncology Research Roundup

oncology · 4 min

ScopeX 2026: Causal AI/ML in Clinical Trials Recap

general · 3 min

IceCure Medical ProSense Revenue Surges 30% in Q1 2026 as Cryoablation Technology Gains Traction

2 min

Partner Therapeutics Submits FDA Application for BIZENGRI in Rare Cholangiocarcinoma Cancer Treatment

FDA · 2 min

FDA Approval Mirvetuximab Soravtansine: Accelerated OK for Elahere in Ovarian Cancer

FDA · Ovarian Cancer · 4 min